Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Obstet Gynecol ; 226(3): 379-383, 2022 03.
Article in English | MEDLINE | ID: mdl-34111406

ABSTRACT

In the past, the reproductive freedom of African American women was hindered by forced reproduction and sterilization campaigns. Unfortunately, these involuntary practices have now mostly been replaced by inequality because of disproportionate tubal factor infertility rates within African American communities. Our work aimed to describe the inequities in increased rates of pelvic inflammatory disease and tubal factor infertility as it relates to African American women. In addition, we highlighted the need for improved access to screening and treatment of sexually transmitted infections, access to barrier contraception, and health literacy related to the understanding and prevention of tubal factor infertility in African American women.


Subject(s)
Infertility, Female , Infertility , Pelvic Inflammatory Disease , Black or African American , Female , Freedom , Humans , Infertility/complications , Infertility, Female/etiology , Pelvic Inflammatory Disease/diagnosis , Reproduction
2.
Clin Perinatol ; 46(2): 187-201, 2019 06.
Article in English | MEDLINE | ID: mdl-31010555

ABSTRACT

Cerebral palsy occurs more often in preterm than in term deliveries and is one of the major neurologic injuries seen in preterm infants. Magnesium sulfate has been found to reduce the risk of cerebral palsy in patients at risk of delivery before 32 weeks' gestational age. Multiple large clinical trials have shown this effect. The authors recommend magnesium sulfate bolus followed by continuous dosing of magnesium sulfate in those at risk of delivery before 32 weeks' gestation until delivery occurs or is no longer imminent. This article also discusses novel and emerging therapies for the prevention of cerebral palsy.


Subject(s)
Cerebral Palsy/prevention & control , Magnesium Sulfate/therapeutic use , Neuroprotective Agents/therapeutic use , Obstetric Labor, Premature , Premature Birth , Darbepoetin alfa/therapeutic use , Erythropoietin/therapeutic use , Female , Hematinics/therapeutic use , Humans , Hypothermia, Induced , Infant, Newborn , Infant, Premature , Ischemic Preconditioning , Maternal-Fetal Exchange , Mesenchymal Stem Cell Transplantation , Neuroprotection , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...